Alan Fuhrman
2023 - Tyra Biosciences
In 2023, Alan Fuhrman earned a total compensation of $3.5M as Chief Financial Officer at Tyra Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $274,560 |
|---|---|
| Option Awards | $2,767,712 |
| Salary | $457,600 |
| Other | $30,933 |
| Total | $3,530,805 |
Fuhrman received $2.8M in option awards, accounting for 78% of the total pay in 2023.
Fuhrman also received $274.6K in non-equity incentive plan, $457.6K in salary and $30.9K in other compensation.
Rankings
In 2023, Alan Fuhrman's compensation ranked 230th out of 2,983 executives tracked by ExecPay. In other words, Fuhrman earned more than 92.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 230 out of 2,983 | 92nd |
Division Manufacturing | 123 out of 1,637 | 93rd |
Major group Chemicals And Allied Products | 84 out of 906 | 91st |
Industry group Drugs | 82 out of 869 | 91st |
Industry Pharmaceutical Preparations | 51 out of 627 | 92nd |
Source: SEC filing on April 18, 2024.
Fuhrman's colleagues
We found two more compensation records of executives who worked with Alan Fuhrman at Tyra Biosciences in 2023.